Skip to main content
Premium Trial:

Request an Annual Quote

Burnham Institute to Use Cyntellect's Imaging System in Collaboration

NEW YORK (GenomeWeb News) – High-speed biomedical imaging company Cyntellect said today that it is collaborating with the Burnham Institute for Medical Research to develop new applications for the company’s in situ cellular imaging tool.
The San Diego-based company said the agreement gives the Burnham researchers access to its LEAP cell imaging and laser processing platform, while Cyntellect gains commercial rights to certain discoveries produced by the collaboration.
The LEAP live cell analysis and processing system incorporates high-speed optical imaging with image analysis and laser cell manipulation, which can be used in cell cloning, image-based cell purification of adherent and non-adherent cell types, and laser-based macromolecule delivery into cells, including siRNA, small molecules, proteins, and quantum dots.
Cyntellect said it expects that the new applications it develops through the collaboration can be used to understand stem cell differentiation factors and pathways and to generate cell populations that could be used as stem cell therapeutics.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.